Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$0.16 - $6.5 $5,615 - $228,143
35,099 New
35,099 $11,000
Q2 2022

Aug 10, 2022

BUY
$0.45 - $1.57 $3,330 - $11,619
7,401 New
7,401 $3,000
Q1 2022

May 16, 2022

SELL
$1.29 - $1.85 $10,396 - $14,909
-8,059 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.19 - $2.42 $8,470 - $17,225
7,118 Added 756.43%
8,059 $14,000
Q3 2021

Nov 15, 2021

SELL
$1.79 - $3.27 $4,662 - $8,518
-2,605 Reduced 73.46%
941 $2,000
Q2 2021

Aug 13, 2021

SELL
$1.72 - $3.19 $8,629 - $16,004
-5,017 Reduced 58.59%
3,546 $11,000
Q1 2021

May 12, 2021

BUY
$1.73 - $3.33 $3,648 - $7,022
2,109 Added 32.68%
8,563 $20,000
Q4 2020

Feb 11, 2021

BUY
$1.67 - $2.63 $7,650 - $12,048
4,581 Added 244.58%
6,454 $11,000
Q3 2020

Nov 12, 2020

SELL
$2.11 - $3.52 $23,927 - $39,916
-11,340 Reduced 85.82%
1,873 $4,000
Q2 2020

Jul 31, 2020

BUY
$2.52 - $4.76 $32,220 - $60,861
12,786 Added 2994.38%
13,213 $46,000
Q1 2020

May 01, 2020

SELL
$2.35 - $8.2 $7,637 - $26,649
-3,250 Reduced 88.39%
427 $2,000
Q4 2019

Feb 14, 2020

BUY
$2.76 - $8.85 $10,148 - $32,541
3,677 New
3,677 $17,000

Others Institutions Holding VERO

# of Institutions
1
Shares Held
7K
Call Options Held
0
Put Options Held
0

About Venus Concept Inc.


  • Ticker VERO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 65,459,600
  • Market Cap $20.9M
  • Description
  • Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...
More about VERO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.